Quality of Life and Physical Performance After Novel Coronavirus Infection (COVID-19);

NCT04375709 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2020-05-12

No results posted yet for this study

Summary

This study aims to observe the long-term health-related quality of life (HRQOL) and physical performance in individuals hospitalized due to a COVID-19 infection. Therefore, data is extracted from a study-site standard aftercare program which has been adjusted for this patient population. This comprehensive aftercare program includes education sessions and physical exercise. A second aim is to observe adherence and feasibility to the program and if indicated compare the clinical data and outcomes from patients following the program with patients denying to participate in guided exercise and education sessions.

It is expected that patients hospitalized due to COVID-19 infection show a reduction in physical performance and HRQOL directly after discharge. The severity of illness is hypothesized to be associated with a reduction as well in HRQOL and physical performance after one-year post-discharge.

Conditions

  • Covid-19 (New Coronavirus) Infection

Interventions

OTHER

Physical exercise

The intervention consists out of combined aerobic and strength exercise supervised and guided by specialized physical therapists; additional methods like functional electrical stimulation or oxygen supplementation are added during the main training if indicated.

BEHAVIORAL

Education sessions

Sessions include information on physical activity (behaviour), coping with stress and anxiety, dyspnoe, or fatigue; Professional support is given in case of risk for nutritional deficits or post-traumatic stress; sessions are conducted by medical specialists or specialized physiotherapists. All sessions are individually-tailored. In case of nutrition or psychological issues individual sessions are guided by specific health-professionals.

Sponsors & Collaborators

  • Kantonsspital Winterthur KSW

    lead OTHER

Principal Investigators

  • David Gisi · Kantonsspital Winterthur KSW

  • Martina Betschart, PhD · Kantonsspital Winterthur KSW

  • Spencer Rezek, MSc Cand. · Kantonsspital Winterthur KSW

  • Ines Unger, MSc Cand. · Kantonsspital Winterthur KSW

  • Natalie Ott, MSc Cand. · Kantonsspital Winterthur KSW

  • Swantje Beyer, MD · Kantonsspital Winterthur KSW

  • Markus Hofer, MD · Kantonsspital Winterthur KSW

  • Karrer Urs, PD MD · Kantonsspital Winterthur KSW

  • Giuseppe Mungo, MSc · Kantonsspital Winterthur KSW

  • Cornel Sieber, Prof. MD · Kantonsspital Winterthur KSW

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-15
Primary Completion
2021-06-30
Completion
2021-08-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04375709 on ClinicalTrials.gov